Between hype and hope: Seattle biotech leaders size up AI’s real impact on drug development
Life Science Washington and Madrona hosted the AI Leadership Forum in Seattle to explore how artificial intelligence is transforming drug discovery, biomanufacturing, and healthcare.
The event brought together leading companies and research institutions to discuss near-term opportunities in AI-powered drug development, emphasizing practical deployment through partnerships and collaboration. “What was science fiction 15 years ago is now reality,” said Erik Procko, Chief Scientist at Cyrus Biotechnology, capturing the sense of rapid progress as biotech and technology continue to converge. Panelists also noted that building trust, validation, and data transparency will be essential for AI to reach its full potential in the life sciences.
By convening leaders across the life sciences and technology sectors, the forum showcased how Seattle’s unique ecosystem, anchored by major tech companies, AI-biotech startups, and world-class research institutions, positions the region at the forefront of AI-driven biotechnology innovation.